Antihyperglycemic and antidyslipidemic activity of aqueous extract of Dioscorea bulbifera tubers

Diabetologia Croatica

Volumn 38, Issue 3, 2009, Pages 63-72

  Ahmed, Zabeer ^a   Chishti, Mohd Zahoor ^b   Johri, Rakesh Kamal ^a   Bhagat, Asha ^a   Gupta, Kuldeep Kumar ^a   Ram, Gandhi ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b UNIVERSITY OF KASHMIR   (India)

Author keywords

Antidyslipidemic; Antihyperglycemic; Dioscorea bulbifera; Fenofibrate; Glibenclamide; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; DIOSCOREA BULBIFERA EXTRACT; GLUCOSE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIABETES MELLITUS; DIOSCOREA BULBIFERA; DIOSCOREACEAE; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIPID BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PLANT TUBER; RAT; TREATMENT DURATION; WEIGHT GAIN; WISTAR RAT;

EID: 73249125843     PISSN: 03510042     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tiwari AK, Madhusudana Rao J. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci 2002;83:30-38.
2. Lazarus SS, Volk BW. Pancreatic adaptation to diabetogenic hormones. Arch Pathol Lab Med 1959;67:456-467.
3. Mohan H. Textbook of pathology, 4th ed. New Delhi: Jaypee Brothers, 2000;802-811.
4. World Health Organisation, Department of Non-communicable Disease Surveillance, 1999.
5. Frank B. The endocrine glands. In: Canine medicine. The work of forty three authors, eds. American Vet. Publ. Inc., California, 1962.
6. Nelson RG, Rettitt DJ, Carraher MJ, Baird HR, et al. Effect of proteinuria on mortality in NIDDM. Diabetes 1988;37:1499-1504.
7. Botazzo GF, Doniach D, Pouplard A. Humoral autoimmunity in diabetes mellitus. Acta Endocrinol 1976;83:55-64.
8. Levine R. Sulfonylureas: background development of the field. Diabetes Care 1984;7:1, 3-7.
9. rd ed. New York: Medical Examination Publishing, 1983:591-610.
10. Schafer G. Biguanides. A review of history, pharmacodynamics, and therapy. Diabetes Metab 1983;9:148-163.
11. Bischoff H. The mechanism of á-glucosidase inhibition in the management of diabetes. Clin Invest Med 1995;18:303-311.
12. Papoushek C. The "glitazones": rosiglitazone and pioglitazone. J Obstet Gynaecol 2003;25:812-815.
13. Ahmed Z, Bhagat A, Gupta OP, Gupta KK, Ram G, Qazi GN. Insulin secretagogue fraction of Argyrolobium roseum. Diabetol Croat 2008;37-3-12.
14. WHO Expert Committee on Diabetes Mellitus. Second report. World Health Organ Tech Rep Ser 1980;646.
15. Coursey DG. Yams, an account of the nature, origins, cultivation and utilization of the useful members of Dioscoreaceae. London: Longman, 1967;230.
16. Van Wyk BE. Air potato as an invasive species. Food plants of the world. Portland, OR: Timber Press, Inc., 2005.
17. Brand-Miller J, Burani J, Foster-Powell K. The new glucose revolution pocket guide to the top 100 low GI foods. 2nd ed. Marlowe & Company, 2003.
18. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-110.
19. Bnouham M, Bellahcen S, Benalla W, Legssyer A, Ziyyat A, Mekhfi H. Antidiabetic activity assessment of Argania spinosa oil. J Complement Integrat Med 2008;5:1.
20. Siddiqui O, Sun Y, Liu JC, Chien YW. Facilitated transdermal transport of insulin. J Pharm Sci 1987;76:341-345.
21. Sorg DC, Buckner B. A simple method of obtaining venous blood from small laboratory animals. Proceedings of the Society for Experimental Biology and Medicine 1964;115:1131-1132.
22. Barham D, Trinder P. An improved color reagent for the determination of blood glucose by the oxidase system. Analyst 1972;97:142-145.
23. Allain CC, Poon LC, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
24. Buccolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-480.
25. Werner M, Gabrielson DG, Eastman G. Ultramicrodeterminations of serum triglycerides by bioluminescent assay. Clin Chem 1981;21:268-271.
26. Annoni G, Bottasso BM, Ciaci D, Donato MF, Tripodi A. Evaluation of a new enzymatic colorimetric method for triglyceride estimation. Res Lab Med 1982;9:115.
27. Lopes-Virella MF, Shere GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA. Surface binding, internalization and degradation by cultured human fibroblasts of LDL isolated from type I (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 1982;22:430-436.
28. Richmond W. Preparation and properties of cholesterol oxidase from Nocardia sp and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973;19:1350-1356.
29. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977;55:767-772.
30. Miller NE, Forde OH, Thelle DS, Mjos OD. High-density lipoprotein and coronary heart disease. A prospective case-control study. Lancet 1977;1:965-968.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
32. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000;43:1528-1533.
33. Kedar P, Chakrabarti CH. Effects of bittergourd (Momordica charantia) seed and glibenclamide in streptozotocin induced diabetes mellitus. Indian J Exp Biol 1982;20:232-235.
34. Esmaeili MA, Yazdanparas R. Hypoglycemic effect of Teucrium polium: studies with rat pancreatic islets. J Ethnopharmacol 2004;95:27-30.
35. Sharma SB, Nasir A, Prabhu KM, Murthy PS. Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. J Ethnopharmacol 2006;104:367-373.
36. Bierman EL, Amaral JAP, Belknap BH. Hyperlipidemia and diabetes mellitus. Diabetes 1966;15:675-679.
37. Garber AJ. Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obes Metab 2002;4:S5-S12.